Skip to search formSkip to main contentSkip to account menu

5-IA-85380

Known as: 5-I-A-85380 
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2012
2012
Pharmacological differences between rat frontal cortex and hippocampus in the nicotinic modulation of noradrenaline release implicate distinct receptor subtypes.
INTRODUCTION Noradrenergic mechanisms in frontal cortex and hippocampus are relevant to attentional and stress-related aspects of… 
2009
2009
18F-ZW-104: A New Radioligand for Imaging Neuronal Nicotinic Acetylcholine Receptors—In Vitro Binding Properties and PET Studies in Baboons
An extensive series of radioligands has been developed for imaging central nicotinic acetylcholine receptors (nAChRs) with PET… 
2004
2004
Functional responses and subunit composition of presynaptic nicotinic receptor subtypes explored using the novel agonist 5-iodo-A-85380
2004
2004
Evaluation of 5-(11)C-methyl-A-85380 as an imaging agent for PET investigations of brain nicotinic acetylcholine receptors.
UNLABELLED Central nicotinic acetylcholine receptors (nAChRs) represent major neurotransmitter receptors responsible for various… 
Review
2003
Review
2003
Keyword index
A Addiction – Psychiatric diagnoses and personality traits associated with disadvantageous decision-making, 455 – The… 
2001
2001
Measurement of plasma metabolites of (S)-5-[123I]iodo-3-(2-azetidinylmethoxy)pyridine (5-IA-85380), a nicotinic acetylcholine receptor imaging agent, in nonhuman primates.
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy (opens in a new tab), Terms of Service (opens in a new tab), and Dataset License (opens in a new tab)